284 related articles for article (PubMed ID: 28139340)
1. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment.
Tittarelli R; Pichini S; Pedersen DS; Pacifici R; Moresco M; Pizza F; Busardò FP; Plazzi G
Forensic Sci Int; 2017 May; 274():70-74. PubMed ID: 28139340
[TBL] [Abstract][Full Text] [Related]
2. Determination of GHB and GHB-β-O-glucuronide in hair of three narcoleptic patients-Comparison between single and chronic GHB exposure.
Mehling LM; Wang X; Johansen SS; Spottke A; Heidbreder A; Young P; Madea B; Hess C
Forensic Sci Int; 2017 Sep; 278():e8-e13. PubMed ID: 28811136
[TBL] [Abstract][Full Text] [Related]
3. Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for determination of GHB, precursors and metabolites in different specimens: Application to clinical and forensic cases.
Busardò FP; Kyriakou C; Marchei E; Pacifici R; Pedersen DS; Pichini S
J Pharm Biomed Anal; 2017 Apr; 137():123-131. PubMed ID: 28110168
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
Borgen LA; Okerholm RA; Lai A; Scharf MB
J Clin Pharmacol; 2004 Mar; 44(3):253-7. PubMed ID: 14973300
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study.
Ingels AS; Hertegonne KB; Lambert WE; Stove CP
CNS Drugs; 2013 Mar; 27(3):233-7. PubMed ID: 23463369
[TBL] [Abstract][Full Text] [Related]
6. GHB levels in breast milk of women with narcolepsy with cataplexy treated with sodium oxybate.
Barker EC; Puchowicz M; Letterio J; Higgins K; Sharkey KM
Sleep Med; 2017 Aug; 36():172-177. PubMed ID: 28668666
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
[TBL] [Abstract][Full Text] [Related]
8. Determination of GHB levels in breast milk and correlation with blood concentrations.
Busardò FP; Bertol E; Mannocchi G; Tittarelli R; Pantano F; Vaiano F; Baglio G; Kyriakou C; Marinelli E
Forensic Sci Int; 2016 Aug; 265():172-81. PubMed ID: 26968013
[TBL] [Abstract][Full Text] [Related]
9. Sodium oxybate: a review of its use in the management of narcolepsy.
Robinson DM; Keating GM
CNS Drugs; 2007; 21(4):337-54. PubMed ID: 17381187
[TBL] [Abstract][Full Text] [Related]
10. Sodium oxybate and sleep apnea: a clinical case.
Hartley S; Quera-Salva MA; Machou M
J Clin Sleep Med; 2011 Dec; 7(6):667-8. PubMed ID: 22171208
[TBL] [Abstract][Full Text] [Related]
11. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
[TBL] [Abstract][Full Text] [Related]
12. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
Moresco M; Pizza F; Antelmi E; Plazzi G
Curr Drug Metab; 2018; 19(13):1073-1079. PubMed ID: 29512449
[TBL] [Abstract][Full Text] [Related]
13. Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails.
Busardò FP; Gottardi M; Tini A; Mortali C; Giorgetti R; Pichini S
Molecules; 2018 Oct; 23(10):. PubMed ID: 30340398
[No Abstract] [Full Text] [Related]
14. A multi-drug intoxication fatality involving Xyrem (GHB).
Akins BE; Miranda E; Lacy JM; Logan BK
J Forensic Sci; 2009 Mar; 54(2):495-6. PubMed ID: 19187456
[TBL] [Abstract][Full Text] [Related]
15. Levels of GHB in hair after regular application.
Nebel A; Mayer G; Hess C; Heidbreder A; Martz W; Veit F
Forensic Sci Int; 2021 Aug; 325():110885. PubMed ID: 34214830
[TBL] [Abstract][Full Text] [Related]
16. The Xyrem risk management program.
Fuller DE; Hornfeldt CS; Kelloway JS; Stahl PJ; Anderson TF
Drug Saf; 2004; 27(5):293-306. PubMed ID: 15061684
[TBL] [Abstract][Full Text] [Related]
17. Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid.
Felmlee MA; Roiko SA; Morse BL; Morris ME
J Pharmacol Exp Ther; 2010 Jun; 333(3):764-71. PubMed ID: 20215411
[TBL] [Abstract][Full Text] [Related]
18. Sodium oxybate-induced central sleep apneas.
Frase L; Schupp J; Sorichter S; Randelshofer W; Riemann D; Nissen C
Sleep Med; 2013 Sep; 14(9):922-4. PubMed ID: 23834969
[TBL] [Abstract][Full Text] [Related]
19. A hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry method for the simultaneous determination of γ-hydroxybutyrate and its precursors in forensic whole blood.
Sørensen LK; Hasselstrøm JB
Forensic Sci Int; 2012 Oct; 222(1-3):352-9. PubMed ID: 22917943
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients.
Scharf MB; Lai AA; Branigan B; Stover R; Berkowitz DB
Sleep; 1998 Aug; 21(5):507-14. PubMed ID: 9703591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
